Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Helios Towers delivers solid first-half performance

(Sharecast News) - Helios Towers delivered a solid first-half performance on Thursday, reporting growth in revenue, profit and free cash flow, and reaffirming its full-year guidance as its '2.2x by 2026' strategy neared completion. Revenue rose 7% year-on-year to $418.3m in the six months ended 30 June, supported by continued tenancy growth across its tower portfolio.

Adjusted EBITDA increased 9% to $225.5m, with the EBITDA margin expanding by one percentage point to 54%.

Free cash flow rose by $39.7m to $29.9m, while recurring free cash flow grew 40% to $69.5m.

Chief executive Tom Greenwood said the results reflected the company's "robust and predictable business model" and its focus on customer experience.

"Accordingly, we reaffirm our guidance for the full year," he said.

Greenwood added that the group's upcoming capital markets day on 6 November would outline a new five-year strategy, "ambitious targets and new capital allocation policy, all of which will position us to maximise value for all our stakeholders".

Operating profit was up 1% to $133.1m, while profit after tax turned positive at $30.9m, compared with a pre-tax loss of $24.5m a year earlier.

The turnaround was driven by a $46m reduction in finance costs, helped by favourable foreign exchange movements, and a $29.7m swing in other gains and losses due to hyperinflation accounting.

The group ended the period with 14,515 sites and 30,617 tenancies, up 2% and 7% year-on-year respectively, lifting the tenancy ratio to 2.11x.

Return on invested capital rose by 0.7 percentage points to 13.6%, and net leverage was reduced to 3.8x, down from 4.2x a year earlier.

Helios Towers maintained its full-year guidance, including 2,000 to 2,500 tenancy additions, adjusted EBITDA of $460m to $470m, and free cash flow of $40m to $60m.

Capital expenditure was expected to be between $150m and $180m, with net leverage forecast at 3.5x.

The company also highlighted continued ESG progress, with an MSCI 'AAA' rating reaffirmed and its inclusion in the FTSE4Good Index for the third year running.

At 1021 BST, shares in Helios Towers were down 1.18% at 117.2p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.